CN116969891A — 一种7-甲基-5-醛基-1h-吲唑的合成方法
Assigned to Hangzhou Guorui Biotechnology Co ltd · Expires 2023-10-31 · 3y expired
What this patent protects
本发明属于化学合成领域，具体涉及一种7‑甲基‑5‑醛基‑1H‑吲唑的合成方法。以2，6‑二甲基‑4‑溴苯胺为起始原料，经氰化、关环和催化加氢反应，得到7‑甲基‑5‑醛基‑1H‑吲唑。本发明避免使用价格昂贵的仲丁基锂试剂，制备成本低；避免了深冷反应，对设备需求要求低，适合产业化生产；本发明7‑甲基‑5‑醛基‑1H‑吲唑的收率高、纯度高、经济效益高，最终产物纯度可达到98.7％，收率92.3％。
USPTO Abstract
本发明属于化学合成领域，具体涉及一种7‑甲基‑5‑醛基‑1H‑吲唑的合成方法。以2，6‑二甲基‑4‑溴苯胺为起始原料，经氰化、关环和催化加氢反应，得到7‑甲基‑5‑醛基‑1H‑吲唑。本发明避免使用价格昂贵的仲丁基锂试剂，制备成本低；避免了深冷反应，对设备需求要求低，适合产业化生产；本发明7‑甲基‑5‑醛基‑1H‑吲唑的收率高、纯度高、经济效益高，最终产物纯度可达到98.7％，收率92.3％。
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.